← Leaderboards
Michael Defoix Caldwell
Marshfield Clinic Research Foundation
$1,043,208
Attributed
$2,819,290
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $608.1K · FY2006–18$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,220,103 · 1
AHRQ$599,187 · 1
By mechanism
R01$2,819,290 · 2
Top collaborators
- Richard A. Hansen4 shared
- Sriraam Natarajan4 shared
- C. David Page4 shared
- Peggy L. Peissig4 shared
Most similar at Marshfield Clinic Research Foundation
Same institution · by research overlap
- Amit Acharya$496,108
Others in their field
Top investigators on “Discipline”
- Leonard Freedman · Leidos Biomedical Research, Inc.$270,520,687
- Steven E Reis · University Of Pittsburgh At Pittsburgh$235,379,739
- Lee Marshall Nadler · Dana-Farber Cancer Inst$192,833,951
- Philip J Disaia · University Of California Irvine$155,333,295
- Garret A Fitzgerald · University Of Pennsylvania$141,741,142
- Elizabeth A Thom · George Washington University$118,013,211
Research focus
DisciplineAdverse Drug EventDiagnosisAttentionAwardBaseBiometryAlgorithmsClinical DataClinical ResearchClinical TrialsCommunitiesComputer ScienceCongressesCostCountryClinicData AnalysesDatabasesData MiningData SetData SourcesDetectionDoctor Of Philosophy
Grant awards (7)
Machine Learning for Identifying Adverse Drug Events$536,041
R01 · FY2018 · GM
Machine Learning for Identifying Adverse Drug Events$536,041
R01 · FY2017 · GM
Machine Learning for Identifying Adverse Drug Events$539,889
R01 · FY2016 · GM
Machine Learning for Identifying Adverse Drug Events$608,132
R01 · FY2015 · GM
Modeling Genotype and other Factors to Enhance the Safety of Warfarin Prescribing$299,504
R01 · FY2007 · HS · contact PI
Modeling Genotype and other Factors to Enhance the Safety of Warfarin Prescribing$4,067
R01 · FY2007 · HS · contact PI
Modeling Genotype and other Factors to Enhance the Safety of Warfarin Prescribing$295,616
R01 · FY2006 · HS · contact PI